Literature DB >> 19792957

Bevacizumab and surgery: what is the real risk?

Richard Cohen, Justin Stebbing, Alastair Windsor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19792957     DOI: 10.2217/fon.09.63

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

Review 1.  Emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Christopher Fung; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

2.  Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study.

Authors:  Toufic Kachaamy; Digant Gupta; Persis Edwin; Pankaj Vashi
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.